AB92. The effect of extensive lymphadenectomy and post operation chemotherapy on patients with node negative gastric cancer
Abstract

AB92. The effect of extensive lymphadenectomy and post operation chemotherapy on patients with node negative gastric cancer

Qiang Xue, Xiao-Na Wang, Han Liang, Ru-Peng Zhang

Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin, China


Aims: To evaluate the therapeutic value of extensive lymphadenectomy and post operation chemotherapy in patients with node negative gastric cancer which is controversial.

Methods: Clinical data of 311 patients without lymph node metastasis were analyzed to evaluate the effect of extensive lymphadenectomy and post operation chemotherapy. The post operation survival rate of patients who underwent lymphadenectomy and post operation chemotherapy was compared with that of patients who underwent standard lymphadenectomy and without postoperative chemotherapy.

Results: The survival rate was poor under the following scenarios: (I) the patients were more than 65 years old; (II) the tumor size is larger than 4 cm; (III) the tumor is located in the upper; (IV) patients were in pT3 status. The survival rate of patients improved significantly by extensive lymphadenectomy only in pT3 status, but not improved in other status. Moreover, there were no significant difference in survival rate between patients with postoperative chemotherapy and patients without postoperative chemotherapy.

Conclusions: Extensive lymphadenectomy prolonged the survival rate of the patients with pT3 node-negative gastric cancer. The patients with node-negative gastric cancer could not benefit from postoperative chemotherapy.

Keywords: Gastric cancer; lymphadenectomy; post-operation chemotherapy; node-negative

Cite this abstract as: Xue Q, Wang XN, Liang H, Zhang RP. The effect of extensive lymphadenectomy and post operation chemotherapy on patients with node negative gastric cancer. Transl Gastrointest Cancer 2013;2(S1):AB92. doi: 10.3978/j.issn.2224-4778.2013.s092